INTERNATIONAL PATENT: TEGMINE THERAPEUTICS, INC. FILES APPLICATION FOR "NOVEL ANTI-STN ANTIBODIES AND METHODS OF USE"

GENEVA, April 8 -- TEGMINE THERAPEUTICS, INC. (4104 24th St., Suite PMB 405San Francisco, California 94114) filed a patent application (PCT/US2025/047928) for "NOVEL ANTI-STN ANTIBODIES AND METHODS OF USE" on Sep 25, 2025. With publication no. WO/2026/072787, the details related to the patent application was published on Apr 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SAHOO, Sanjaya Kumar (c/o Tegmine Therapeutics, Inc.4104 24th St., Suite PMB 405San Francisco, California 94114), SHIINA, Marisa (c/o Tegmine Therapeutics, Inc.4104 24th St., Suite PMB 405San Francisco, California 94114...